Načítá se...
Recent advances in the management of renal cell carcinoma
Therapeutic options for patients with metastatic renal cell carcinoma have significantly improved over the past few years with the recent approval of two new agents resulting in prolonged progression-free and overall survival.
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000Research
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4806703/ https://ncbi.nlm.nih.gov/pubmed/27019698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.7935.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|